Alexandria Equities
Alexandria® - Building the Future of Life Science™.
Launch date
Employees
Market cap
€19.8b
Enterprise valuation
€30.9b (Public information from Sep 2024)
Share price
$123.86 ARE
Pasadena California (HQ)
Corporate Venture Fund: Alexandria Venture Investments
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.9b | 2.1b | 2.6b | 2.9b | 3.1b | 3.3b | 3.5b |
| % growth | 23 % | 12 % | 22 % | 11 % | 7 % | 7 % | 6 % |
| EBITDA | 1.2b | 1.4b | 1.6b | 1.8b | 2.0b | 2.1b | 2.2b |
| % EBITDA margin | 65 % | 64 % | 63 % | 63 % | 65 % | 64 % | 62 % |
| Profit | 771m | 571m | 522m | 104m | 498m | 591m | 495m |
| % profit margin | 41 % | 27 % | 20 % | 4 % | 16 % | 18 % | 14 % |
| EV / revenue | 16.5x | 20.3x | 12.8x | 11.3x | 10.6x | 9.9x | 9.4x |
| EV / EBITDA | 25.2x | 31.8x | 20.4x | 17.9x | 16.1x | 15.5x | 15.1x |
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | N/A | IPO |
| N/A | $220k | Post IPO Equity | |
* | N/A | N/A | Post IPO Debt |
* | N/A | Post IPO Equity | |
| Total Funding | - | ||
Recent News about Alexandria Equities
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Alexandria Equities
Edit
ACQUISITION by PPD Apr 2009
ACQUISITION by Biodesix Jul 2018
